Takaomi Tomioka is a Managing Director advising on Japanese buyout opportunities in the consumer and healthcare sectors. He is based in Tokyo.
Prior to joining Carlyle, Mr. Tomioka worked at General Electric Capital Corporation from 1998 to 2003. While at GE, he served as Director and Representative at GE Equity Japan, a private equity arm of GE. While at GE Equity Japan, Mr. Tomioka was responsible for the investment and management of portfolio companies, serving as either a board member. He served at the Long-Term Credit Bank of Japan from 1985 to 1998, including nine years of corporate financing both in the U.S. and Japan. He has initiated deals for Qualicaps, Solasto Corp. (formerly N.I.C.Corp), Oyatsu Company Ltd., Sansho Pharmaceutical Co. Ltd. and Meisui Bijin Factory Co., Ltd. (formerly Kyushu GGC Ltd.).
He is currently a board member at Solasto Corp. (formerly N.I.C.Corp), Oyatsu Company Ltd., Sunsho Pharmaceutical Co., Ltd., and Meisui Bijin Factory Co., Ltd. (formerly Kyushu GGC Ltd.).
Mr. Tomioka received his B.A. in law at Waseda University and his M.B.A. at New York University.